Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

The Cycle Characteristics and Outcomes of Infertile Nonclassic 21-Hydroxylase Deficiency Patients Undergoing Ovarian Stimulation for In Vitro Fertilization.

Jiang S, Kuang Y.

Horm Metab Res. 2019 May;51(5):315-325. doi: 10.1055/a-0893-3122. Epub 2019 May 9.

PMID:
31071736
3.
4.

Influence of GnRH antagonist in reproductive women on in vitro fertilization and embryo transfer in fresh cycles.

Xu Y, Zhang YS, Zhu DY, Zhai XH, Wu FX, Wang AC.

Biomed Rep. 2019 Feb;10(2):113-118. doi: 10.3892/br.2018.1176. Epub 2018 Nov 29.

5.

[Value of serum inhibin B measurement in predicting ovarian response in controlled ovarian hyperstimulation for in vitro fertilization cycle].

Chen Y, Yu Q, Zhang YW, He FF, Sun ZY.

Zhonghua Fu Chan Ke Za Zhi. 2006 Jun;41(6):368-71. Chinese.

PMID:
16831355
6.

The pregnancy outcome of progestin-primed ovarian stimulation using 4 versus 10 mg of medroxyprogesterone acetate per day in infertile women undergoing in vitro fertilisation: a randomised controlled trial.

Dong J, Wang Y, Chai WR, Hong QQ, Wang NL, Sun LH, Long H, Wang L, Tian H, Lyu QF, Lu XF, Chen QJ, Kuang YP.

BJOG. 2017 Jun;124(7):1048-1055. doi: 10.1111/1471-0528.14622.

8.

Flexibility in starting ovarian stimulation at different phases of the menstrual cycle for treatment of infertile women with the use of in vitro fertilization or intracytoplasmic sperm injection.

Qin N, Chen Q, Hong Q, Cai R, Gao H, Wang Y, Sun L, Zhang S, Guo H, Fu Y, Ai A, Tian H, Lyu Q, Daya S, Kuang Y.

Fertil Steril. 2016 Aug;106(2):334-341.e1. doi: 10.1016/j.fertnstert.2016.04.006. Epub 2016 Apr 22.

PMID:
27114329
9.

Modified natural cycle versus controlled ovarian hyperstimulation IVF: a cost-effectiveness evaluation of three simulated treatment scenarios.

Groen H, Tonch N, Simons AH, van der Veen F, Hoek A, Land JA.

Hum Reprod. 2013 Dec;28(12):3236-46. doi: 10.1093/humrep/det386. Epub 2013 Oct 27.

PMID:
24166594
10.

Do poor-responder patients benefit from increasing the daily gonadotropin dose during controlled ovarian hyperstimulation for IVF?

Haas J, Zilberberg E, Machtinger R, Kedem A, Hourvitz A, Orvieto R.

Gynecol Endocrinol. 2015 Jan;31(1):79-82. doi: 10.3109/09513590.2014.959919. Epub 2014 Sep 16.

PMID:
25223892
13.

GnRH antagonist for patients with polycystic ovary syndrome undergoing controlled ovarian hyperstimulation for in vitro fertilization and embryo transfer in fresh cycles.

Zhai XH, Zhang P, Wu FX, Wang AC, Liu PS.

Exp Ther Med. 2017 Jun;13(6):3097-3102. doi: 10.3892/etm.2017.4309. Epub 2017 Apr 5.

14.

Basal progesterone level as the main determinant of progesterone elevation on the day of hCG triggering in controlled ovarian stimulation cycles.

Papaleo E, Corti L, Vanni VS, Pagliardini L, Ottolina J, De Michele F, La Marca A, Viganò P, Candiani M.

Arch Gynecol Obstet. 2014 Jul;290(1):169-76. doi: 10.1007/s00404-014-3167-y. Epub 2014 Feb 19.

PMID:
24549270
15.

Is it the egg or the endometrium? Elevated progesterone on day of trigger is not associated with embryo ploidy nor decreased success rates in subsequent embryo transfer cycles.

Kofinas JD, Mehr H, Ganguly N, Biley Y, Bochkovsky S, McCulloh D, Grifo J.

J Assist Reprod Genet. 2016 Sep;33(9):1169-74. doi: 10.1007/s10815-016-0752-y. Epub 2016 Jun 4.

16.

The serum level of C-reactive protein in patients undergoing GnRH agonist protocols for in vitro fertilization cycle.

Liu B, Zhang L, Guo RW, Wang WJ, Duan XQ, Liu YW.

Clin Exp Obstet Gynecol. 2014;41(2):190-4.

PMID:
24779250
17.

Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles.

Toftager M, Bogstad J, Bryndorf T, Løssl K, Roskær J, Holland T, Prætorius L, Zedeler A, Nilas L, Pinborg A.

Hum Reprod. 2016 Jun;31(6):1253-64. doi: 10.1093/humrep/dew051. Epub 2016 Apr 8.

PMID:
27060174
18.

Triggering ovulation with gonadotropin-releasing hormone agonist in in vitro fertilization patients with polycystic ovaries does not cause ovarian hyperstimulation syndrome despite very high estradiol levels.

Manzanares MA, Gómez-Palomares JL, Ricciarelli E, Hernández ER.

Fertil Steril. 2010 Mar 1;93(4):1215-9. doi: 10.1016/j.fertnstert.2008.12.019. Epub 2009 Feb 6.

PMID:
19200978
19.
20.

Estimating the net effect of progesterone elevation on the day of hCG on live birth rates after IVF: a cohort analysis of 3296 IVF cycles.

Venetis CA, Kolibianakis EM, Bosdou JK, Lainas GT, Sfontouris IA, Tarlatzis BC, Lainas TG.

Hum Reprod. 2015 Mar;30(3):684-91. doi: 10.1093/humrep/deu362. Epub 2015 Jan 12.

PMID:
25586787

Supplemental Content

Support Center